These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29854302)

  • 21. Semaphorin 3A lytic hybrid peptide binding to neuropilin-1 as a novel anti-cancer agent in pancreatic cancer.
    Ueyama H; Horibe T; Nakajima O; Ohara K; Kohno M; Kawakami K
    Biochem Biophys Res Commun; 2011 Oct; 414(1):60-6. PubMed ID: 21945444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Semaphorin 3A promotes activation of Pax7, Myf5, and MyoD through inhibition of emerin expression in activated satellite cells.
    Qahar M; Takuma Y; Mizunoya W; Tatsumi R; Ikeuchi Y; Nakamura M
    FEBS Open Bio; 2016 Jun; 6(6):529-39. PubMed ID: 27239431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis.
    Zhang B; Gao Z; Sun M; Li H; Fan H; Chen D; Zheng J
    J Surg Oncol; 2015 Mar; 111(4):382-8. PubMed ID: 25475162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SSeCKS/AKAP12 induces repulsion between human prostate cancer and microvessel endothelial cells through the activation of Semaphorin 3F.
    Xie W; Su W; Zhang L; Shang Q; Su B
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1394-1398. PubMed ID: 28698137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Semaphorin 3A neutralization monoclonal antibody prevents sepsis development in lipopolysaccharide-treated mice.
    Yamashita N; Jitsuki-Takahashi A; Ogawara M; Ohkubo W; Araki T; Hotta C; Tamura T; Hashimoto S; Yabuki T; Tsuji T; Sasakura Y; Okumura H; Takaiwa A; Koyama C; Murakami K; Goshima Y
    Int Immunol; 2015 Sep; 27(9):459-66. PubMed ID: 25855660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
    Nassehi D
    Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglia and interleukin-1β in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A.
    Rivera JC; Sitaras N; Noueihed B; Hamel D; Madaan A; Zhou T; Honoré JC; Quiniou C; Joyal JS; Hardy P; Sennlaub F; Lubell W; Chemtob S
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1881-91. PubMed ID: 23766263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Satellite cells produce neural chemorepellent semaphorin 3A upon muscle injury.
    Sato Y; DO MK; Suzuki T; Ohtsubo H; Mizunoya W; Nakamura M; Furuse M; Ikeuchi Y; Tatsumi R
    Anim Sci J; 2013 Feb; 84(2):185-9. PubMed ID: 23384361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus-mediated delivery of Sema3A alleviates rheumatoid arthritis in a serum-transfer induced mouse model.
    Teng Y; Yin Z; Li J; Li K; Li X; Zhang Y
    Oncotarget; 2017 Sep; 8(39):66270-66280. PubMed ID: 29029510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression.
    Futamura M; Kamino H; Miyamoto Y; Kitamura N; Nakamura Y; Ohnishi S; Masuda Y; Arakawa H
    Cancer Res; 2007 Feb; 67(4):1451-60. PubMed ID: 17308083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semaphorin-3F suppresses the stemness of colorectal cancer cells by inactivating Rac1.
    Rao J; Zhou ZH; Yang J; Shi Y; Xu SL; Wang B; Ping YF; Chen L; Cui YH; Zhang X; Wu F; Bian XW
    Cancer Lett; 2015 Mar; 358(1):76-84. PubMed ID: 25529012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas.
    Barresi V; Tuccari G
    Neuropathology; 2010 Oct; 30(5):537-46. PubMed ID: 20337947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of the semaphorin 3A pathway in prostatic cancer.
    Yacoub M; Coulon A; Celhay O; Irani J; Cussenot O; Fromont G
    Histopathology; 2009 Oct; 55(4):392-8. PubMed ID: 19817889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.
    Kigel B; Varshavsky A; Kessler O; Neufeld G
    PLoS One; 2008 Sep; 3(9):e3287. PubMed ID: 18818766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the plexin-A2 receptor in Sema3A and Sema3B signal transduction.
    Sabag AD; Smolkin T; Mumblat Y; Ueffing M; Kessler O; Gloeckner CJ; Neufeld G
    J Cell Sci; 2014 Dec; 127(Pt 24):5240-52. PubMed ID: 25335892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Semaphorin 3A is expressed in human osteoarthritic cartilage and antagonizes vascular endothelial growth factor 165-promoted chondrocyte migration: an implication for chondrocyte cloning.
    Okubo M; Kimura T; Fujita Y; Mochizuki S; Niki Y; Enomoto H; Suda Y; Toyama Y; Okada Y
    Arthritis Rheum; 2011 Oct; 63(10):3000-9. PubMed ID: 21953086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct roles for Sema3A, Sema3F, and an unidentified trophic factor in controlling the advance of geniculate axons to gustatory lingual epithelium.
    Vilbig R; Cosmano J; Giger R; Rochlin MW
    J Neurocytol; 2004 Dec; 33(6):591-606. PubMed ID: 16217616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of class 3 semaphorins and their receptors in human breast neoplasia.
    Staton CA; Shaw LA; Valluru M; Hoh L; Koay I; Cross SS; Reed MW; Brown NJ
    Histopathology; 2011 Aug; 59(2):274-82. PubMed ID: 21884206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semaphorin-induced cytoskeletal collapse and repulsion of endothelial cells.
    Bielenberg DR; Shimizu A; Klagsbrun M
    Methods Enzymol; 2008; 443():299-314. PubMed ID: 18772022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semaphorin 3A - a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus.
    Vadasz Z; Toubi E
    Lupus; 2012 Oct; 21(12):1266-70. PubMed ID: 22875653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.